Adenocarcinoma of the esophagogastric junction

1 paper1 finding

Humans1

Effects

1

Overall survival

downin humans1

1 study

Adenocarcinoma of the esophagogastric junction decreases overall survival in humans.
“Overall survival but not disease-free survival was worse for AEG compared to GNCC.”
Humanscompared to GNCC
Constitutively active Akt-mediated cellular senescence inhibits apoptosis in adenocarcinoma of the esophagogastric junction
Tissue & cell27 Jun 2025

Trial sponsors

University Hospital Schleswig-Holstein
1 trialPhase 3438 people
Krankenhaus Nordwest
2 trialsPhase 2395 people
Technical University of Munich
1 trialPhase 275 people
University Hospital, Essen
1 trialPhase 221 people

Latest

Tissue & Cell2 Jul

Constitutively active Akt-mediated cellular senescence inhibits apoptosis in adenocarcinoma of the esophagogastric junction

Cohort study in peopleApoptosis